{"id":"W2907628865","doi":"10.1016/j.cllc.2018.12.017","title":"Durable Clinical Response to Crizotinib in IRF2BP2-NTRK1 Non–small-cell Lung Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"ca_institutions":"Public Health Ontario","funders":"","keywords":"Trk receptor; Tropomyosin receptor kinase B; Tropomyosin receptor kinase A; Tropomyosin receptor kinase C; Receptor tyrosine kinase; Crizotinib; Cancer research; Tyrosine kinase; Neurotrophin; Lung cancer; Medicine; Low-affinity nerve growth factor receptor; Kinase; Internal medicine; Receptor; Biology; Cell biology; Platelet-derived growth factor receptor; Neurotrophic factors; Growth factor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003794417,0.0002698471,0.0007556846,0.0001425854,0.0002459325,0.0004935836,0.0002467487,0.0002792474,0.002725163],"category_scores_gemma":[0.0006449365,0.00009482163,0.0005372131,0.000221534,0.0001602219,0.0002916688,0.0001929288,0.0009152658,0.0008137895],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001260656,"about_ca_system_score_gemma":0.0005126372,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001936657,"about_ca_topic_score_gemma":0.01119482,"domain_scores_codex":[0.9997992,0.00002623586,0.00002029246,0.00003815209,0.00003755387,0.00007861955],"domain_scores_gemma":[0.9997733,0.00004029114,0.00004273932,0.00002847039,0.00003282511,0.00008238431],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"case_report","study_design_scores_codex":[0.02727531,0.001593305,0.05987835,0.001010318,0.001213199,0.004190196,0.0001651274,0.003697535,0.1563683,0.00110421,0.03724236,0.7062618],"study_design_scores_gemma":[0.01913913,0.04563166,0.5596254,0.0003951372,0.003364331,0.04123151,0.0005991825,0.01159551,0.103542,0.004359485,0.2103386,0.0001781565],"study_design_candidate":"case_report","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9572529,0.01672466,0.001331989,0.002892369,0.0003178896,0.0002553733,0.003065316,0.0002894653,0.01786998],"genre_scores_gemma":[0.9883342,0.002239408,0.0005627763,0.001018596,0.00008271207,0.00007834905,0.004333482,0.00003145282,0.003318995],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002725163,"threshold_uncertainty_score":0.00914675,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04866820201861862,"score_gpt":0.4836031825458398,"score_spread":0.4349349805272212,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}